Investment Rating - The report maintains a "Buy" rating for China Hongqiao (01378.HK) [6] Core Views - In 2025, China Hongqiao achieved a revenue of 162.35 billion RMB, a year-on-year increase of 4%, and a net profit of 22.64 billion RMB, a year-on-year increase of 1% [1] - The company experienced a decline in revenue and net profit in the second half of 2025, primarily due to a significant drop in alumina prices and reduced aluminum processing sales [1] - The company has made significant advancements in new materials, technologies, and processes, solidifying its leading position in the global aluminum alloy materials and green manufacturing sectors [3] - The cash dividend for 2025 was 14.475 billion RMB, with a payout ratio of 64%, reflecting the company's operational confidence [3] Financial Summary - Revenue for 2025 was 162.35 billion RMB, with a growth rate of 4% year-on-year [5] - The net profit for 2025 was 22.64 billion RMB, with a growth rate of 1.2% year-on-year [5] - The estimated net profit for 2026-2028 is projected to be 32.27 billion RMB, 36.55 billion RMB, and 40.68 billion RMB, respectively, with corresponding P/E ratios of 9.4, 8.3, and 7.4 [4][5] - The company’s EPS for 2025 is 2.27 RMB per share, with a projected increase to 3.23 RMB per share in 2026 [5] Production and Pricing - In 2025, the company sold 13.397 million tons of alumina, a year-on-year increase of 22.7%, while aluminum sales were 5.824 million tons, a slight decrease of 0.2% [1][2] - The average selling price of electrolytic aluminum (excluding tax) in 2025 was 18,216 RMB per ton, a year-on-year increase of 4%, while the price of alumina was 2,899 RMB per ton, a year-on-year decrease of 15% [2] - The gross profit margin for alumina in 2025 was 643 RMB per ton, a decrease of 47% year-on-year, while the gross profit margin for electrolytic aluminum was 5,183 RMB per ton, an increase of 20% year-on-year [2]

Investment Rating - The report assigns a rating of "Buy" for Alibaba Group (9988.HK) [2][12]. Core Insights - The report highlights that Alibaba's strategic investments are under short-term pressure, but the AI flywheel is continuously strengthening. The company aims for a five-year target of $100 billion in AI revenue, with increasing visibility on this path [3][11]. - Alibaba's revenue for FY26Q3 was reported at 284.8 billion RMB, showing a year-on-year growth of 2%. Excluding disposed businesses, the same-store revenue growth was 9% [11][12]. - The report indicates a clear recovery signal for Q4, driven by improved consumer demand and the efficiency of instant retail operations [11][12]. Financial Summary - Revenue projections for Alibaba are adjusted to 1,031.2 billion RMB for FY2026, 1,142.0 billion RMB for FY2027, and 1,268.8 billion RMB for FY2028, reflecting growth rates of 3.5%, 10.8%, and 11.1% respectively [5][12]. - Non-GAAP net profit is projected to be 90.3 billion RMB for FY2026, 136.0 billion RMB for FY2027, and 161.1 billion RMB for FY2028, with a non-GAAP net profit margin of 8.8% for FY2026 [5][12]. - The adjusted PE ratio is forecasted to be 23.1 for FY2026, decreasing to 15.3 for FY2027 and 12.9 for FY2028 [5][12]. Market Data - The current stock price of Alibaba is 123.70 HKD, with a market capitalization of 2,362.6 million HKD [2][8]. - The stock has traded within a range of 101.30 to 185.10 HKD over the past 52 weeks [8]. Business Segments - The report emphasizes the strong growth in Alibaba's cloud business, with revenue for FY26Q3 reaching 43.3 billion RMB, a year-on-year increase of 36% [11][12]. - Instant retail revenue grew by 56% year-on-year, indicating a successful strategy in improving fulfillment efficiency and optimizing order structure [11][12]. Valuation - The target price for Alibaba is set at 183 HKD based on a sum-of-the-parts (SOTP) valuation method, reflecting a strong outlook for the company's core businesses [12][13].

Investment Rating - The report maintains a "Strong Buy" investment rating for the company [1][7]. Core Views - The company demonstrates steady growth and financial health, with a commitment to high dividends, as evidenced by its announcement of a cash dividend for 2025 [1][7]. - The company's revenue for 2025 is projected to reach 162.35 billion yuan, reflecting a year-on-year growth of 4% [3][9]. - The net profit attributable to shareholders is expected to be 22.64 billion yuan for 2025, showing a slight increase of 1.2% year-on-year, indicating stable core profitability [7][9]. - The report highlights the company's integrated business model and its ability to maintain robust profitability despite fluctuations in raw material prices [7]. Financial Data and Valuation - Total revenue is projected to grow from 156.17 billion yuan in 2024 to 178.34 billion yuan in 2028, with a compound annual growth rate (CAGR) of approximately 4.5% [3][9]. - Operating profit is expected to increase significantly from 36.25 billion yuan in 2024 to 53.79 billion yuan in 2028, with a notable growth of 140% in 2024 [3][9]. - The earnings per share (EPS) is forecasted to rise from 2.25 yuan in 2024 to 3.51 yuan in 2028, reflecting a strong upward trend in profitability [3][10]. - The price-to-earnings (PE) ratio is projected to decrease from 22.0 in 2024 to 14.1 in 2028, indicating an attractive valuation over time [3][10]. Dividend Policy - The company plans to distribute a final dividend of 1.65 Hong Kong cents per share for 2025, with a total cash dividend amounting to 14.475 billion Hong Kong dollars, resulting in a dividend payout ratio of 57.76% and a dividend yield of 5.06% [7][9]. Business Development - The company has successfully launched several projects, including the world's first large-scale NEUI600+ super electrolytic cell production line and a high-precision aluminum alloy project, which are expected to enhance its resource attributes and profitability [7][9].

Investment Rating - The report maintains a "Buy" rating for the company [6][10]. Core Insights - In 2025, despite a continued decline in revenue, the company achieved a 16% year-on-year growth in net profit attributable to shareholders, driven by reduced financial expenses and alleviated impairment pressures in green environmental sectors. The dividend payout ratio increased to 42.3% [2][10]. - The company reported a total revenue of HKD 27.521 billion in 2025, a decrease of 9% compared to 2024, while net profit reached HKD 3.925 billion, reflecting a 16% increase year-on-year. The total dividend for the year was HKD 1.659 billion, up 17% from HKD 1.413 billion in 2024 [10]. - The construction service revenue fell by 53% to HKD 2.681 billion, accounting for about 10% of total revenue, while operational service revenue grew by approximately 3% to HKD 19.426 billion, indicating a shift towards stable operational income [10]. - Financial expenses were significantly reduced to HKD 2.394 billion in 2025, down about 20% from HKD 3.007 billion in 2024, contributing to the overall profit recovery [10]. - The green environmental sector turned profitable in 2025, with an EBITDA of HKD 1.639 billion, a 62% increase year-on-year, and a net profit contribution of HKD 0.087 billion, recovering from a loss of HKD 0.285 billion in 2024 [10]. Financial Summary - Total revenue for 2025 was HKD 27,521 million, with a projected increase to HKD 28,814 million in 2026 and HKD 29,013 million in 2027 [4]. - Net profit for 2025 was HKD 3,925 million, expected to rise to HKD 4,287 million in 2026 and HKD 4,624 million in 2027 [4]. - The company’s PE ratio for 2025 is 7.5, with projections of 7.4 for 2026 and 6.8 for 2027 [4]. - The PB ratio is projected to be 0.57 in 2025, increasing slightly to 0.58 in 2026 and decreasing to 0.55 in 2027 [4].

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company is expected to experience a slight decline in performance in 2025, with revenue projected at 5.518 billion yuan (down 0.4% year-on-year) and net profit at 1.915 billion yuan (down 7.1% year-on-year) [3] - Despite the competitive industry landscape, the company is anticipated to maintain strong product capabilities and continue new iterations, leading to a reasonable valuation [3] - The forecast for net profit from 2026 to 2028 is set at 1.956 billion yuan, 2.184 billion yuan, and 2.445 billion yuan respectively, with corresponding EPS of 1.83 yuan, 2.04 yuan, and 2.28 yuan [3] Financial Summary - Revenue for 2025 is reported at 55.18 billion yuan, with a slight decline of 0.4% year-on-year, while net profit is 19.15 billion yuan, reflecting a decrease of 7.1% [3][4] - The gross margin for 2025 is 80.3%, down 1.8 percentage points, influenced by product category structure [4] - The company’s operating income is projected to grow to 6.120 billion yuan in 2026, with a year-on-year increase of 10.9% [6] - The P/E ratio is expected to be 14.8 in 2026, decreasing to 11.8 by 2028, indicating a favorable valuation trend [6] Product and Market Development - The company has received regulatory approval for two types of recombinant collagen medical devices, marking its entry into the skin rejuvenation market and demonstrating its R&D capabilities [5] - The product line includes the upgraded Collagen Stick 2.0 and the newly launched Collagen Big Mask King 3.0, which have received positive market feedback [5] - The company is expanding its market presence internationally, with products now available in Singapore, Malaysia, South Korea, and North America [5]

Investment Rating - The investment rating for the company is "Buy" [8] Core Views - The company reported a revenue of 49.1 billion yuan for 2025, a year-on-year increase of 10.9%, and a net profit attributable to shareholders of 9.08 billion yuan, up 3.0% year-on-year, which is in line with expectations [1] - The "anti-involution" policy has led to a significant recovery in profitability since the second half of 2025, driven by rising express delivery prices [1] - The company plans to return at least 50% of the previous fiscal year's adjusted net profit to shareholders through cash dividends and share buybacks starting in 2026 [2] Revenue and Profitability - In Q4 2025, the adjusted net profit was 2.63 billion yuan, with a quarter-on-quarter change of -1.6% and a year-on-year change of +5.4% [1] - The company announced a year-end dividend of $0.39 per share, corresponding to a payout ratio of 40% [1] - The single ticket revenue in Q4 2025 was 1.35 yuan, reflecting a quarter-on-quarter increase of 2.9% and a year-on-year increase of 13.7% [3] Market Share and Volume - The company achieved a market share of 19.6% in Q4 2025, an increase of 4.1 percentage points quarter-on-quarter [3] - The total express delivery volume for Q4 was 10.6 billion pieces, with a quarter-on-quarter increase of 9.2% and a year-on-year increase of 10.3% [3] - The company expects a year-on-year growth rate of 10% to 13% in express delivery volume for 2026 [3] Cost Efficiency - The single ticket cost for trunk and sorting in 2025 was 0.62 yuan, a decrease of 0.06 yuan year-on-year, primarily due to economies of scale, automation investments, and route optimization [4] - The company anticipates a further reduction in single ticket costs by 0.02 yuan year-on-year in 2026 [4] Future Outlook - The report maintains profit forecasts for 2026 and 2027, with net profit estimates of 10.66 billion yuan and 12.11 billion yuan, respectively [6] - The target price has been raised by 23% to 228.0 HKD (29.1 USD), based on a PE ratio of 14.5x for 2026 [6] - The company is expected to continue benefiting from the "anti-involution" policy, which should support both volume and revenue growth [1][5]

Investment Rating - The report maintains a "Buy" rating for the company [3][6] Core Views - The company's profitability is expected to stabilize and grow due to product premiumization and international expansion [2][10] - The company forecasts net profits for 2026-2028 to be 20.48 billion, 25.94 billion, and 30.81 billion RMB respectively, with a target price set at 20.79 RMB or 23.65 HKD [3][10] Financial Summary - Revenue projections for 2024A to 2028E are as follows: 275.91 billion, 345.23 billion, 421.56 billion, 488.32 billion, and 580.92 billion RMB, with year-on-year growth rates of 25.1%, 22.1%, 15.8%, and 19.0% respectively [5][11] - Operating profit is expected to grow significantly, with figures of 6.68 billion, 17.66 billion, 22.91 billion, 29.40 billion, and 35.10 billion RMB for the same years, reflecting growth rates of 164.4%, 29.8%, 28.3%, and 19.4% [5][11] - The gross margin is projected to improve slightly, reaching 16.8% in 2026 and 17.2% in 2027 and 2028 [5][10] - The company aims to sell 302.46 million vehicles in 2025, a 39.0% increase year-on-year, with electric vehicle sales expected to reach 168.78 million, a 90.0% increase [10] Market Performance - The company's stock price as of March 20, 2026, was 19.52 HKD, with a 52-week high of 20.78 HKD and a low of 12.7 HKD [6] - The report indicates that the company's absolute performance over the past week, month, and year has been positive, with respective increases of 12.18%, 16.19%, and 9.07% [7] Strategic Initiatives - The company is focusing on high-end product development and international market expansion, with plans to launch new models and technologies in the coming years [10] - The export volume is expected to grow significantly, with a target of 640,000 units in 2026, representing a 52% increase [10]

Investment Rating - The report initiates coverage with an "Overweight" rating for the company [1][6] Core Insights - The Hong Kong property market is entering a cycle of simultaneous increases in both transaction volume and prices, supported by favorable conditions such as rising rental yields and declining unsold inventory [5][10] - The company ranks among the top two in land reserves in Hong Kong, with diverse land acquisition channels and significant cost advantages, positioning it well for future growth [10][60] - The company benefits from dual cash flow engines, with stable income from core commercial assets and dividends from its stake in Hong Kong and China Gas, ensuring consistent dividend payouts [10][85] - The forecast for core net profit from 2025 to 2027 is HK$8.068 billion, HK$9.114 billion, and HK$10.306 billion, reflecting a recovery in profitability [5][10] Summary by Sections Company Overview - Founded in 1976, the company primarily engages in property development and investment, with a diversified portfolio including Hong Kong and China Gas, and various hotel and real estate investments [18] Market Analysis (β) - The Hong Kong property market is showing signs of recovery, with a rental yield of 3.43% surpassing the average mortgage rate of 3.25%, indicating a shift towards buying rather than renting [5][34] - The Central City Leading Index (CCL) has reached new highs, suggesting increased buyer confidence [10][34] - The number of completed but unsold units has decreased significantly, indicating a tightening supply [10][34] Company Strengths (α) - The company holds a land bank of 11.9 million square feet, ranking it second among Hong Kong developers, with a focus on low-cost land acquisition through various methods [10][60] - Urban redevelopment projects are strategically located in prime areas, enhancing potential profitability [10][60] Cash Flow Analysis - The company maintains a stable dividend policy, with total dividends from 2019 to 2024 amounting to HK$8.715 billion, and a consistent dividend per share of HK$1.80 [10][74] - Core commercial assets contribute significantly to rental income, with a stable occupancy rate across its properties [10][74] Financial Analysis - The company’s core net profit for the first half of 2025 decreased by 44% due to reduced land compensation income, but profitability is expected to recover as new projects are launched [90] - The company’s total revenue for the first half of 2025 was HK$95.52 billion, reflecting a year-on-year decline of 18.8% [26][90]

Investment Rating - The report maintains a "Buy" rating for the company [4] Core Insights - The company reported a total revenue of USD 2.619 billion for 2025, reflecting a year-on-year growth of 2.41%. However, the net profit attributable to shareholders decreased by 14.76% to USD 787 million [10] - The company's core business showed stable growth, with a significant improvement in actual revenue growth when excluding a one-time insurance payout of USD 170 million from the previous year. The adjusted revenue growth for 2025 was 9.72% [10] - The company’s fleet size increased to 815 aircraft by the end of 2025, with a utilization rate of 100%. The delivery of aircraft exceeded expectations, with 51 aircraft delivered in total for the year [10] - The company announced a final dividend of USD 0.3061 per share, resulting in a total annual dividend of USD 0.4537 per share, which corresponds to a payout ratio of 40%, up from 35% in 2024 [10] Financial Forecasts - Revenue projections for 2026, 2027, and 2028 are USD 2.720 billion, USD 2.859 billion, and USD 3.033 billion, respectively, with year-on-year growth rates of 3.87%, 5.09%, and 6.10% [3] - Net profit forecasts for the same years are USD 825 million, USD 887 million, and USD 959 million, with growth rates of 4.78%, 7.47%, and 8.14% [3] - The company’s earnings per share (EPS) are projected to be USD 1.19, USD 1.28, and USD 1.38 for 2026, 2027, and 2028, respectively [3] Market Position and Outlook - The aircraft leasing market remains robust, with a backlog of 21,520 aircraft orders from Boeing and Airbus, indicating sustained high demand [10] - The company holds a significant order backlog of 337 aircraft, positioning it to benefit from the ongoing market growth [10] - The report highlights that the company’s price-to-book (PB) ratios for the next three years are projected to be 0.9, 0.9, and 0.8, indicating a favorable valuation [3]

Investment Rating - The report maintains a "Buy" rating for the company, indicating a positive outlook for its stock performance relative to the benchmark index [4]. Core Insights - The company, 巨子生物 (2367.HK), reported a slight decline in revenue and profit for the year ending December 31, 2025, with total revenue of 55.19 billion yuan, down 0.37% year-on-year, and a net profit of 19.15 billion yuan, down 7.15% year-on-year [1]. - The company's gross margin was 80.34%, a decrease of 1.76 percentage points compared to the previous year, while the net profit margin fell to 34.70%, down 2.54 percentage points year-on-year [1]. - The second half of 2025 saw a significant impact from public sentiment issues, leading to a revenue drop of 19.76% and a net profit decline of 32.10% [1]. - The company is recognized as a leading player in the global recombinant collagen market, focusing on research and development to expand its eight consumer brands [4]. Financial Performance Summary - For 2025, the company achieved a revenue of 55.19 billion yuan, with a year-on-year decrease of 0.37%, and a net profit of 19.15 billion yuan, reflecting a 7.15% decline [1][6]. - The company forecasts net profits for 2026, 2027, and 2028 to be 19.49 billion yuan, 21.34 billion yuan, and 23.45 billion yuan, respectively, with corresponding price-to-earnings ratios of 15, 14, and 12 times [4][6]. - The revenue is expected to grow to 61.17 billion yuan in 2026, representing a year-on-year increase of 10.85% [6].